Table 3.

Hypoglycaemia through 24 weeks.

	Dulaglutide 1.5 mg	Placebo
Hypoglycaemia	n = 239	n = 60
Total hypoglycaemia(†)
Incidence, n (%)	50 (20.9)*	2 (3.3)
Rate (events/patient/year), mean (sd)	2.37 (7.2)*	0.07 (0.39)
Documented symptomatic‡
Incidence, n (%)	27 (11.3)*	1 (1.7)
Rate (events/patient/year), mean (s.d.)	0.90 (3.97)	0.04 (0.28)
Nocturnal‡
Incidence n (%)	16 (6.7)	1 (1.7)
Rate (events/patient/year), mean (s.d)	0.29 (1.89)	0.04 (0.28)
Severe hypoglycaemia	0 (0.0)	0 (0.0)

Intention‐to‐treat population. s.d., standard deviation.

^*p < 0.05 versus placebo.

^†Plasma glucose ≤3.9 mmol/l (70 mg/dl) ± symptoms.

^‡Plasma glucose ≤3.9 mmol/l (70 mg/dl).